Cover Image
市場調查報告書

神經血管裝置的全球市場預測 2027年:腦栓塞、動脈瘤線圈設備,腦血管造影術、支架系統,輔助設備,腦血栓消除設備

Global Neurovascular Devices Market Forecast to 2027: Cerebral Embolization and Aneurysm Coiling Devices, Cerebral Angioplasty and Stenting Systems, Support Devices, Neurothrombectomy Devices

出版商 Visiongain Ltd 商品編碼 608853
出版日期 內容資訊 英文 152 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
神經血管裝置的全球市場預測 2027年:腦栓塞、動脈瘤線圈設備,腦血管造影術、支架系統,輔助設備,腦血栓消除設備 Global Neurovascular Devices Market Forecast to 2027: Cerebral Embolization and Aneurysm Coiling Devices, Cerebral Angioplasty and Stenting Systems, Support Devices, Neurothrombectomy Devices
出版日期: 2018年01月11日 內容資訊: 英文 152 Pages
簡介

全球心血管設備市場,預計在預測期間的前半部分以10.3%的年複合成長率成長。腦栓塞、動脈瘤線圈設備市場區隔,在該市場構成著最大的佔有率。

本報告提供全球心血管設備市場相關分析,市場基本結構和主要的促進、阻礙因素,全球整體及市場區隔、各地區/國家的市場趨勢預測,市場定性分析,主要企業的簡介的資訊彙整,為您概述為以下內容。

第1章 調查概要

第2章 心血管疾病的簡介

  • 概要
  • 中風
  • 腦動脈狹窄
  • 腦動脈瘤
  • 動靜脈畸形、動靜脈瘺

第3章 全球心血管設備市場預測

第4章 主要心血管設備次市場預測

  • 全球市場的設備的結構
  • 主要的心血管疾病設備市場預測
    • 腦栓塞、動脈瘤線圈設備
    • 腦血管造影術、支架系統
    • 輔助設備
    • 腦血栓消除設備

第5章 心血管設備:主要地區、各國市場的預測

  • 全球市場的地區結構
  • 主要地區、各國市場的預測
    • 美國
    • EU5個國家
    • 日本
    • 金磚四國
    • 其他 (ROW)

第6章 心血管設備市場SWOT分析

  • 優勢
  • 弱點
  • 機會
  • 威脅

第7章 主要企業

  • Stryker Corporation
  • Medtronic
  • Johnson & Johnson
  • Terumo Corporation
  • Penumbra

第8章 結論

  • 心血管設備市場預測
  • 持有美國最大的佔有率
  • 腦栓塞、動脈瘤線圈設備獨佔心血管設備市場

附錄

目錄
Product Code: PHA0274

The global neurovascular devices market is expected to grow at a CAGR of 10.3% in the first half of the forecast period. In 2016, the Cerebral Embolization and Aneurysm Coiling Devices segment held the largest share in the global neurovascular devices market.

How this report will benefit you

Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 152-page report you will receive 85 charts- all unavailable elsewhere.

The 152-page report provides clear detailed insight into the global neurovascular devices market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand-new report today you stay better informed and ready to act.

image1

Report Scope

  • Global Neurovascular Devices market forecasts to 2027
  • This report also breaks down the revenue forecast for the global neurovascular market by submarket
    • Cerebral Embolization and Aneurysm Coiling Devices
    • Cerebral Angioplasty and Stenting Systems
    • Support Devices
    • Neurothrombectomy Devices
  • This report provides individual revenue forecasts to 2027 for these regional and national markets:
    • The US
    • EU5: Germany, France, the UK, Italy, Spain
    • Japan
    • BRIC: Brazil, Russia, India, China
    • Rest of the World (RoW)
  • Our study gives qualitative analysis of the neurovascular devices market. It discusses the SWOT analysis of the neurovascular devices market.
  • Our study discusses the selected leading companies that are the major players in the neurovascular devices industry:
    • Stryker Corporation
    • Medtronic
    • Johnson & Johnson
    • Terumo
    • Penumbra

Visiongain's study is intended for anyone requiring commercial analyses for the global b neurovascular devices market. You find data, trends and predictions.

Table of Contents

1. Report Overview

  • 1.1 Global Neurovascular Devices Market Overview
  • 1.2 Why You Should Read This Report
  • 1.3 How This Report Delivers
  • 1.4 Key Questions Answered by This Analytical Report Include:
  • 1.5 Who is This Report For?
  • 1.6 Methodology
    • 1.6.1 Primary Research
    • 1.6.2 Secondary Research
    • 1.6.3 Market Evaluation & Forecasting Methodology
  • 1.7 Frequently Asked Questions (FAQ)
  • 1.8 Associated Visiongain Reports
  • 1.9 About Visiongain

2. Introduction to Neurovascular Diseases

  • 2.1 Overview
  • 2.2 Stroke
    • 2.2.1 Types of Strokes
      • 2.2.1.1 Ischaemic stroke:
      • 2.2.1.2 Haemorrhagic stroke:
  • 2.3 Cerebral Artery Stenosis
    • 2.3.1 Diagnosis
    • 2.3.2 Treatment of Cerebral Artery Stenosis
      • 2.3.2.1 Angioplasty
      • 2.3.2.2 Cerebral artery bypass
  • 2.4 Cerebral Aneurysm
    • 2.4.1 Causes of Cerebral Aneurysm
    • 2.4.2 Types of Aneurysms
    • 2.4.3 Prevalence of Aneurysms
    • 2.4.4 Diagnosis of Aneurysms
    • 2.4.5 Treatment of Aneurysms
  • 2.5 Arteriovenous Malformation and Fistulas
    • 2.5.1 Types of AVMs
    • 2.5.2 Epidemiology
    • 2.5.3 Diagnosis of AVM
    • 2.5.4 Treatment of AVMs

3. Global Neurovascular Devices Market Forecast to 2027

  • 3.1 The Global Neurovascular Devices Market Forecast to 2027

4. Leading Neurovascular Devices Submarket Forecast to 2027

  • 4.1 Devices Composition of the Global Market in 2016 and 2027
  • 4.2 Leading Devices Markets for Neurovascular Devices Forecast to 2027
    • 4.2.1 Cerebral Embolization and Aneurysm Coiling Devices
      • 4.2.1.1 Cerebral Embolization and Aneurysm Coiling Devices Market Forecast to 2027
    • 4.2.2 Cerebral Angioplasty and Stenting Systems
      • 4.2.2.1 Cerebral Angioplasty and Stenting Systems Market Forecast to 2027
    • 4.2.3 Support Devices
      • 4.2.3.1 Support Devices Market Forecast to 2027
    • 4.2.4 Neurothrombectomy Devices
      • 4.2.4.1 Neurothrombectomy Devices Market Forecast to 2027

5. Neurovascular Devices: Leading Regional and National Market Forecast to 2027

  • 5.1 Regional Composition of the Global Market in 2016 and 2027
  • 5.3 Leading Regional and National Markets for Neurovascular Devices Market Forecast to 2027
    • 5.3.1 US Neurovascular Devices Market Forecast to 2027
      • 5.3.1.1 The US Will Dominate Throughout the Forecast Period
      • 5.3.1.2 US Neurovascular Devices Market Forecast to 2027
    • 5.3.2 EU5 Neurovascular Devices Market Forecast to 2027
      • 5.3.2.1 German Neurovascular Devices Market: Leader in EU, but Facing Big Reforms
        • 5.3.2.1.1 German Neurovascular Devices Market Forecast to 2027
      • 5.3.2.2 French Neurovascular Devices Market: Strong National Healthcare System, Despite Economic Woes
        • 5.3.2.2.1 French Neurovascular Devices Market Forecast to 2027
      • 5.3.2.3 Italian Neurovascular Devices Market
        • 5.3.2.3.1 Italian Neurovascular Devices Market Forecast to 2027
      • 5.3.2.4 UK Neurovascular Devices Market: Pricing is a Key Issue, Providing Restraints to Revenues
        • 5.3.2.4.1 UK Neurovascular Devices Market Forecast to 2027
      • 5.3.2.5 Spanish Neurovascular Devices Market
        • 5.3.2.5.1 Spanish Neurovascular Devices Market Forecast to 2027
    • 5.3.3 Japanese Neurovascular Devices Market
      • 5.3.3.1 Japanese Neurovascular Devices Market Forecast to 2027
    • 5.3.4 BRIC Neurovascular Devices Market Forecast to 2027
      • 5.3.4.1 China Neurovascular Devices Market: Rapid Growth Will Make it one of the Major Global Players
        • 5.3.4.1.1 China Neurovascular Devices Market Forecast to 2027
      • 5.3.4.2 Brazilian Neurovascular Devices Market: Taken Great Strides Forward with Healthcare
        • 5.3.4.2.1 Brazilian Neurovascular Devices Market Forecast to 2027
      • 5.3.4.3 Russian Neurovascular Devices Market: Punches Below its Weight
        • 5.3.4.3.1 Russian Neurovascular Devices Market Forecast to 2027
      • 5.3.4.4 Indian Neurovascular Devices Market
        • 5.3.4.4.1 Indian Neurovascular Devices Market Forecast to 2027
    • 5.3.5 Rest of the World (ROW)
      • 5.3.5.1 ROW Neurovascular Devices Market Forecast, 2016-2027

6. SWOT Analysis of the Neurovascular Devices Market

  • 6.1 Strengths
    • 6.1.1 Aging Population
    • 6.1.2 Rising Incidence of Obesity
    • 6.1.3 High Incidence of Strokes
    • 6.1.4 Increasing Demand for Minimally Invasive Procedures
    • 6.1.5 Technological Advancements
  • 6.2 Weakness
    • 6.2.1 Disadvantages of Neurovascular Devices
  • 6.3 Opportunities
    • 6.3.1 Healthcare expenditures
  • 6.4 Threats
    • 6.4.1 High Cost of R&D Activities

7. Leading Companies

  • 7.1 Stryker Corporation
    • 7.1.1 Introduction
    • 7.1.2 Recent Performance Analysis
    • 7.1.3 Total Company Sales by Business Segments,2016
    • 7.1.4 Stryker Products
  • 7.2 Medtronic
    • 7.2.1 Introduction
    • 7.2.2 Recent Performance Analysis
    • 7.2.3 Total Company Sales by Business Segments,2017
    • 7.2.4 Medtronic Products
  • 7.3 Johnson & Johnson
    • 7.3.1 Introduction
    • 7.3.2 Recent Performance Analysis
    • 7.3.3 Total Company Sales by Business Segments,2016
    • 7.3.4 Johnson & Johnson Products
  • 7.4 Terumo
    • 7.4.1 Introduction
    • 7.4.2 Recent Performance Analysis
    • 7.4.3 Total Company Sales by Business Segments,2016
    • 7.4.4 Terumo Products
  • 7.5 Penumbra
    • 7.5.1 Introduction
    • 7.5.2 Recent Performance Analysis
    • 7.5.3 Total Company Sales by Business Segments,2016
    • 7.5.4 Penumbra Products

8. Conclusion

  • 8.1 Neurovascular Devices Market Forecast
  • 8.2 The US has the Largest Share
  • 8.3 Cerebral Embolization and Aneurysm Coiling Devices Dominates the Neurovascular Devices Market

Appendices

  • Associated Visiongain Reports
  • Visiongain Report Sales Order Form
  • Appendix A
  • About Visiongain
  • Appendix B
  • Visiongain report evaluation form

List of Figures

  • Figure 3.1 Global Neurovascular Devices Market Forecast: Revenues ($bn), 2016-2027
  • Figure 4.1 Devices Composition of the Global Neurovascular Devices Market: Revenues ($bn), Market Share (%), 2016
  • Figure 4.2 Devices Composition of the Global Neurovascular Devices Market: Revenues ($bn), Market Share (%), 2027
  • Figure 4.3 Devices Forecasts for the Global Neurovascular Devices Market: Revenues ($bn), 2016-2027
  • Figure 4.4 Cerebral Embolization and Aneurysm Coiling Devices Market Forecast: Revenues ($bn), 2016-2027
  • Figure 4.5 Cerebral Angioplasty and Stenting Systems Market Forecast: Revenues ($bn), 2016-2027
  • Figure 4.6 Support Devices Market Forecast: Revenues ($bn), 2016-2027
  • Figure 4.7 Neurothrombectomy Devices Market Forecast: Revenues ($bn), 2016-2027
  • Figure 5.1 Regional Composition of the Global Neurovascular Devices Market: Revenues ($bn), Market Share (%), 2016
  • Figure 5.2 Regional Composition of the Global Neurovascular Devices Market: Revenues ($bn), Market Share (%), 2027
  • Figure 5.3 Regional Forecasts for the Global Neurovascular Devices Market: Revenues ($bn), 2016-2027
  • Figure 5.4 US Neurovascular Devices Market Forecast: Revenues ($bn), 2016-2027
  • Figure 5.5 German Neurovascular Devices Market Forecast: Revenues ($bn), 2016-2027
  • Figure 5.6 French Neurovascular Devices Market Forecast: Revenues ($bn), 2016-2027
  • Figure 5.7 Italian Neurovascular Devices Market Forecast: Revenues ($bn), 2016-2027
  • Figure 5.8 UK Neurovascular Devices Market Forecast: Revenues ($bn), 2016-2027
  • Figure 5.9 Spanish Neurovascular Devices Market Forecast: Revenues ($bn), 2016-2027
  • Figure 5.10 Japanese Neurovascular Devices Market Forecast: Revenues ($bn), 2016-2027
  • Figure 5.11 Chinese Neurovascular Devices Market Forecast: Revenues ($bn), 2016-2027
  • Figure 5.12 Brazilian Neurovascular Devices Market Forecast: Revenues ($bn), 2016-2027
  • Figure 5.13 Russian Neurovascular Devices Market Forecast: Revenues ($bn), 2016-2027
  • Figure 5.14 Indian Neurovascular Devices Market Forecast: Revenues ($bn), 2016-2027
  • Figure 5.15 ROW Neurovascular Devices Market Forecast: Revenues ($bn), 2016-2027
  • Figure 6.1 Stryker: Sales by Business Segments, 2016
  • Figure 6.2 Medtronic: Sales by Business Segments, 2017
  • Figure 6.3 Johnson & Johnson: Sales by Business Segments, 2016
  • Figure 6.4 Terumo: Sales by Business Segments, 2016
  • Figure 6.5 Penumbra: Sales by Business Segments, 2016
  • Figure 8.1 Global Neurovascular Devices Market by Region ($bn) (2016 and 2021)
  • Figure 8.2 Global Neurovascular Devices Market by Region ($bn) (2022 and 2027)
  • Figure 8.3 Global Neurovascular Devices Market by Device Type ($bn) (2016, 2022, 2027)

List of Tables

  • Table 3.1 Global Neurovascular Devices Market Forecast: Revenues ($bn), AGR (%), CAGR (%), 2016-2021
  • Table 3.2 Global Neurovascular Devices Market Forecast: Revenues ($bn), AGR (%), CAGR (%), 2022-2027
  • Table 4.1 Devices Forecasts for the Global Neurovascular Devices Market: Revenues ($bn), AGR (%), CAGR (%), Market Share (%), 2016-2021
  • Table 4.2 Devices Forecasts for the Global Neurovascular Devices Market: Revenues ($bn), AGR (%), CAGR (%), Market Share (%), 2022-2027
  • Table 4.3 Cerebral Embolization and Aneurysm Coiling Devices Market: Revenues ($bn), AGR (%), CAGR (%), Market Share (%), 2016-2021
  • Table 4.4 Cerebral Embolization and Aneurysm Coiling Devices Market: Revenues ($bn), AGR (%), CAGR (%), Market Share (%), 2022-2027
  • Table 4.5 Cerebral Angioplasty and Stenting Systems Market: Revenues ($bn), AGR (%), CAGR (%), Market Share (%), 2016-2021
  • Table 4.6 Cerebral Angioplasty and Stenting Systems Market: Revenues ($bn), AGR (%), CAGR (%), Market Share (%), 2022-2027
  • Table 4.7 Support Devices Market: Revenues ($bn), AGR (%), CAGR (%), Market Share (%), 2016-2021
  • Table 4.8 Support Devices Market: Revenues ($bn), AGR (%), CAGR (%), Market Share (%), 2022-2027
  • Table 4.9 Neurothrombectomy Devices Market: Revenues ($bn), AGR (%), CAGR (%), Market Share (%), 2016-2021
  • Table 4.10 Neurothrombectomy Devices Market: Revenues ($bn), AGR (%), CAGR (%), Market Share (%), 2022-2027
  • Table 5.1 Regional Forecasts for the Global Neurovascular Devices Market: Revenues ($bn), AGR (%), CAGR (%), Market Share (%), 2016-2021
  • Table 5.2 Regional Forecasts for the Global Neurovascular Devices Market: Revenues ($bn), AGR (%), CAGR (%), Market Share (%), 2022-2027
  • Table 5.3 US Neurovascular Devices Market: Revenues ($bn), AGR (%), CAGR (%), Market Share (%), 2016-2021
  • Table 5.4 US Neurovascular Devices Market: Revenues ($bn), AGR (%), CAGR (%), Market Share (%), 2022-2027
  • Table 5.5 German Neurovascular Devices Market: Revenues ($bn), AGR (%), CAGR (%), Market Share (%), 2016-2021
  • Table 5.6 German Neurovascular Devices Market: Revenues ($bn), AGR (%), CAGR (%), Market Share (%), 2022-2027
  • Table 5.7 French Neurovascular Devices Market: Revenues ($bn), AGR (%), CAGR (%), Market Share (%), 2016-2021
  • Table 5.8 French Neurovascular Devices Market: Revenues ($bn), AGR (%), CAGR (%), Market Share (%), 2022-2027
  • Table 5.9 Italian Neurovascular Devices Market: Revenues ($bn), AGR (%), CAGR (%), Market Share (%), 2016-2021
  • Table 5.10 Italian Neurovascular Devices Market: Revenues ($bn), AGR (%), CAGR (%), Market Share (%), 2022-2027
  • Table 5.11 UK Neurovascular Devices Market: Revenues ($bn), AGR (%), CAGR (%), Market Share (%), 2016-2021
  • Table 5.12 UK Neurovascular Devices Market: Revenues ($bn), AGR (%), CAGR (%), Market Share (%), 2022-2027
  • Table 5.13 Spanish Neurovascular Devices Market: Revenues ($bn), AGR (%), CAGR (%), Market Share (%), 2016-2021
  • Table 5.14 Spanish Neurovascular Devices Market: Revenues ($bn), AGR (%), CAGR (%), Market Share (%), 2022-2027
  • Table 5.15 Japanese Neurovascular Devices Market: Revenues ($bn), AGR (%), CAGR (%), Market Share (%), 2016-2021
  • Table 5.16 Japanese Neurovascular Devices Market: Revenues ($bn), AGR (%), CAGR (%), Market Share (%), 2022-2027
  • Table 5.17 Chinese Neurovascular Devices Market: Revenues ($bn), AGR (%), CAGR (%), Market Share (%), 2016-2021
  • Table 5.18 Chinese Neurovascular Devices Market: Revenues ($bn), AGR (%), CAGR (%), Market Share (%), 2022-2027
  • Table 5.19 Brazilian Neurovascular Devices Market: Revenues ($bn), AGR (%), CAGR (%), Market Share (%), 2016-2021
  • Table 5.20 Brazilian Neurovascular Devices Market: Revenues ($bn), AGR (%), CAGR (%), Market Share (%), 2022-2027
  • Table 5.21 Russian Neurovascular Devices Market: Revenues ($bn), AGR (%), CAGR (%), Market Share (%), 2016-2021
  • Table 5.22 Russian Neurovascular Devices Market: Revenues ($bn), AGR (%), CAGR (%), Market Share (%), 2022-2027
  • Table 5.23 Indian Neurovascular Devices Market: Revenues ($bn), AGR (%), CAGR (%), Market Share (%), 2016-2021
  • Table 5.24 Indian Neurovascular Devices Market: Revenues ($bn), AGR (%), CAGR (%), Market Share (%), 2022-2027
  • Table 5.25 ROW Neurovascular Devices Market: Revenues ($bn), AGR (%), CAGR (%), Market Share (%), 2016-2021
  • Table 5.26 ROW Neurovascular Devices Market: Revenues ($bn), AGR (%), CAGR (%), Market Share (%), 2022-2027
  • Table 6.1 Global Neurovascular Devices Market SWOT Analysis 2016-2027
  • Table 6.2 Healthcare Expenditure (% of GDP)
  • Table 7.1 Stryker: Sales and Market shares by Business Segments, 2016
  • Table 7.2 Stryker Products
  • Table 7.3 Medtronic: Sales and Market shares by Business Segments, 2017
  • Table 7.4 Medtronic Products
  • Table 7.5 Johnson & Johnson: Sales and Market shares by Business Segments, 2016
  • Table 7.6 Johnson & Johnson Products
  • Table 7.7 Terumo: Sales and Market shares by Business Segments, 2016
  • Table 7.8 Terumo Products
  • Table 7.9 Penumbra: Sales and Market shares by Business Segments, 2016
  • Table 7.10 Penumbra Products
  • Table 8.1 Global Neurovascular Devices Market Forecast ($m) (2016, 2021, 2027)
  • Table 8.2 Global Neurovascular Devices Market by Region ($bn) (2016 and 2021)
  • Table 8.3 Global Neurovascular Devices Market by Region ($bn) (2022 and 2027)
  • Table 8.4 Global Neurovascular Devices Market by Device Type ($bn) (2016, 2022, 2027)

Companies Listed

  • Angiotech Technologies, Inc
  • Balt Extrusion
  • Biosphere Medical
  • Boston Scientific Corporation
  • Chestnut Medical Technologies
  • Codman Neuro
  • Concentric Medical
  • Cordis Corporation
  • Cork Ltd.
  • Cork, Ireland
  • Covidien
  • Edap Technomed Japan
  • EKOS
  • Endovasix
  • Ev3 Medical
  • FDA
  • Johnson & Johnson
  • Lumen Biomedical, Inc
  • Mauna Kea Technologies
  • Medtronic Invatec
  • Medtronic, Inc
  • Neuravi
  • Omnisonics Medical Technologies
  • Penumbra
  • Pfizer
  • Possis Medical
  • Solution
  • Spectanetics
  • Stryker Corporation
  • Stryker Neurovascular
  • Target Therapeutics
  • Terumo
  • Upjohn

List of Organizations Mentioned in the Report

  • American Heart Association
  • Cambridge University Hospitals NHS Foundation Trust
  • Center for Biologics Evaluation and Research (CBER)
  • Center for Devices and Radiological Health (CDRH)
  • Centers for Disease Control and Prevention (CDC)
  • Central Drug Standards Control Organization (CDSCO)
  • China Food and Drug Administration (CFDA)
  • Department of Health (DoH)
  • Department of Health and Association of the British Pharmaceutical Industry
  • Department of Health and Human Services (HHS)
  • European Federation of Pharmaceutical Industries and Associations (EFPIA)
  • European Union (EU)
  • Federal Food, Drug, and Cosmetic Act (FFDCA)
  • International Society for NeuroVascular Disease
  • Japan's Ministry of Health, Labor and Welfare (MHLW)
  • Medical Device Directive (MDD)
  • Medical Device Regulatory Authority of India (MDRA)
  • National Health Service (NHS)
  • National Institute for Health and Care Excellence (NICE)
  • Oxford University Hospitals
  • Sheffield Teaching Hospitals
  • South London and Maudsley Hospitals
  • SSN (Servizio Sanitario Nazionale)
  • Therapeutic Goods Administration (TGA)
  • University College London Hospitals
  • World Bank
Back to Top